Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 1/20 | 0.40 |
| ▸ | ACACA | Q13085 | 1/20 | 0.40 |
| ▸ | RARB | P10826 | 1/20 | 0.38 |
| ▸ | PRKCA | P17252 | 4/20 | 0.36 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.35 |
| ▸ | KDM4A | O75164 | 1/20 | 0.35 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.35 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | NAAA | Q02083 | 1/20 | 0.32 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.31 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28378738 | 0.95 | PRKCA (0.38) | ACACBACACARARBPRKCAKDM4C | |
| SCHEMBL29467087 | 0.95 | PRKCA (0.38) | ACACBACACARARBPRKCAKDM4C | |
| SCHEMBL29365868 | 0.95 | PRKCA (0.38) | ACACBACACARARBPRKCAKDM4C | |
| SCHEMBL22830548 | 0.95 | PRKCA (0.38) | ACACBACACARARBPRKCAKDM4C | |
| SCHEMBL3323623 | 0.95 | PRKCA (0.38) | ACACBACACARARBPRKCAKDM4C | |
| SCHEMBL24652860 | 0.95 | PRKCA (0.38) | ACACBACACARARBPRKCAKDM4C | |
| SCHEMBL2523056 | 0.95 | PRKCA (0.38) | ACACBACACARARBPRKCAKDM4C | |
| SCHEMBL10498226 | 0.93 | PRKCA (0.39) | ACACBACACARARBPRKCAKDM4C | |
| SCHEMBL30142647 | 0.92 | ACACB (0.51) | ACACBACACARARBPRKCACYP4F2 | |
| SCHEMBL30455911 | 0.91 | ACACB (0.54) | ACACBACACARARBPRKCACYP4F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110098231-A1 | Skin Cosmetic | SHISEIDO COMPANY, LTD. (JP) | 2011-04-28 | — | — | US | disclosed |
| EP-2168568-A1 | SKIN COSMETIC | Shiseido Company, Limited (JP) | 2010-03-31 | — | — | EP | disclosed |
| US-20090258964-A1 | Skin Cosmetic | SHISEIDO COMPANY, LTD. (JP) | 2009-10-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090258964-A1 | Skin Cosmetic | CUTA, DEGS1, ALAD | ACACB 1198/4885ACACA 1184/4885RARB 537/4885 |
| US-20110098231-A1 | Skin Cosmetic | CUTA, DEGS1, ALAD | ACACB 1198/4885ACACA 1184/4885RARB 537/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.